NCT05011175

Brief Summary

This study aims to evaluate the exercise regimens of individuals with Parkinson's.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
138

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2020

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2020

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

August 16, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 18, 2021

Completed
Last Updated

August 18, 2021

Status Verified

August 1, 2021

Enrollment Period

5 months

First QC Date

August 16, 2021

Last Update Submit

August 16, 2021

Conditions

Keywords

ExerciseSurvey

Outcome Measures

Primary Outcomes (12)

  • Age

    Average age of participants enrolled

    Reported at baseline

  • Self-reported age of Parkinson's Disease Diagnosis

    Average age of diagnosis with Parkinson's Disease for enrolled participants.

    Reported at baseline

  • Self-reported education level

    Number of participants reporting 1. less than 12 years of school, 2. completed high school, 3. completed bachelor degree, 4. completed graduate/advanced degree.

    Reported at baseline

  • Self-reported living situation

    Number of participants reporting 1.living alone, 2. living with others 3. living in a healthcare facility

    Reported at baseline

  • Self-reported number of years taking medicine for Parkinson's Disease

    Average number of years participants reported taking medication for Parkinson's Disease

    Reported at baseline

  • Self-reported brain stimulation treatment

    Number of participants reporting they have undergone deep brain stimulation for Parkinson's Disease.

    Reported at baseline

  • Self-reported stage of Parkinson's Disease

    Average reported stage of Parkinson's Disease participants (1. mild with no symptoms, 2. mild with symptoms, 3. moderate, 4. advanced, able to walk 5. advanced, unable to walk).

    Reported at baseline

  • Self-reported physical help requirement

    Number of participants reporting 1. they need help from another person during the day or 2. they do not need help from another person during the day.

    Reported at baseline

  • Self-reported walking ability

    Number of participants reporting 1. ability to walk unaided, 2. ability to walk with an assistive device, or 3. requiring assistance to walk

    Reported at baseline

  • Self-reported mobility level

    Participants reported mobility level ranging from independent to total assist required.

    Reported at baseline

  • Self-reported current exercise habits survey

    3 question survey component evaluating the exercise habits of individuals with Parkinson's Disease using a Likert scale from 0-5 where 5 indicated a higher levels of exercise.

    Reported at baseline

  • Perceived levels of intensity

    7 question survey evaluating the level of intensity of exercise of individuals with Parkinson's Disease using a Likert scale from 0-5 where 5 indicated higher levels of intensity.

    Reported at baseline

Study Arms (1)

Individuals with Parkinson's Disease

Individuals that have been diagnosed with Parkinson's Disease will be enrolled to participant in the survey research.

Other: Survey

Interventions

SurveyOTHER

Participants responded to questions about their exercise habits and perceived levels of intensity as well as demographic information.

Individuals with Parkinson's Disease

Eligibility Criteria

Age40 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Individuals ages 40-90 years old who have been diagnosed with Parkinson's Disease.

You may qualify if:

  • Diagnosed with Parkinson's Disease
  • Able to speak English

You may not qualify if:

  • No internet access

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Kentucky

Lexington, Kentucky, 40506, United States

Location

MeSH Terms

Conditions

Parkinson DiseaseMotor Activity

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative DiseasesBehavior

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Jordana Lockwich, PT, DPT

    University of Kentucky

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Graduate Student

Study Record Dates

First Submitted

August 16, 2021

First Posted

August 18, 2021

Study Start

May 1, 2020

Primary Completion

September 30, 2020

Study Completion

September 30, 2020

Last Updated

August 18, 2021

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will not share

Locations